Seth Lederman

Seth Lederman

Chief Executive Officer at TONIX PHARMACEUTICALS HOLDING CORP.

Net worth: 357 656 $ as of 30/05/2026

68 year
Health Technology
Consumer Services
Finance

Profile

Seth Lederman founded Ivrea Pharmaceuticals, Inc. in 2005, Tonix Pharmaceuticals, Inc. in 2007, where he is working as Chairman & President from 2010, Tonix Pharmaceuticals Holding Corp.
in 2007, where he is working as Chairman, President & Chief Executive Officer from 2011, and various other companies.
Dr. Lederman also founded Validus LLC, where he worked as Chairman and Vela Pharmaceuticals, Inc., where he worked as Chairman from 2007 to 2008.
Dr. Lederman also currently works at Starling Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2011, Krele LLC, as Chairman from 2010, Tonix Pharmaceuticals (Canada), Inc., as President & Director from 2013, and various other companies.
Dr. Lederman also formerly worked at Tamandare Explorations, Inc., as Chairman, President & Chief Executive Officer in 2011, Leder Laboratories, Inc., as Chairman & Chief Executive Officer from 2011 to 2018, Validus Pharmaceuticals LLC, as Chairman from 2007 to 2008, and various other companies.
Dr. Lederman received his undergraduate degree in 1979 from Princeton University and doctorate degree in 1983 from Columbia University College of Physicians & Surgeons.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
08/06/2026 29,007 ( 0.25% ) 357 656 $ 30/05/2026

Seth Lederman active positions

CompaniesPositionStart
TONIX PHARMACEUTICALS HOLDING CORP. Chief Executive Officer 15/11/2007
Tonix Pharmaceuticals (Canada), Inc.
President 31/03/2013
Starling Pharmaceuticals, Inc.
Chief Executive Officer 30/11/2011
Lederman Seth Co. LLC
Corporate Officer/Principal 31/12/2006
Chairman 15/08/2010
Founder 06/06/2007

Former positions of Seth Lederman

CompaniesPositionEnd
L&L Technologies, Inc.
Corporate Officer/Principal 28/02/2025
Plumbline LLC
Corporate Officer/Principal 28/02/2025
Lederman & Co. LLC
Corporate Officer/Principal 28/02/2025
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ ░░ ░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Seth Lederman's experience

Training of Seth Lederman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

28

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies28

Health Technology

Health Technology

Retail Trade

Non-Energy Minerals

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Targent Pharmaceuticals LLC

Lederman & Co. LLC

L&L Technologies, Inc.

Health Technology

Plumbline LLC

Validus LLC

Lederman Seth Co. LLC

Leder Laboratories, Inc.

Starling Pharmaceuticals, Inc.

Consumer Services

Tonix Pharmaceuticals (Canada), Inc.

Tonix Pharmaceuticals (Barbados) Ltd.

Health Technology

Tonix Pharma Holdings Ltd.

Fontus Pharmaceuticals, Inc.

Finance

Finance

Konanda General Partner LLC

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!